LicianPro

TRVI holders · CITADEL ADVISORS LLC 13F · TRVI stock

CITADEL ADVISORS LLC Trevi Therapeutics Inc (TRVI) 13F holding

CITADEL ADVISORS LLC reported 1,201,489 TRVI shares valued at $14.3M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest TRVI 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the TRVI holders table.

TRVI reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-311,201,489$14.3MCOM
2025-12-31152,855$1.9MCOM
2025-09-30102,534$938.2KCOM
2025-06-301,319,266$7.2MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.